All In MedTech

Device Trial Radar · NCT01058629

Study to Evaluate the Clinical Performance of SynergEyes A2 Hybrid Contact Lenses

A 180 Day, Multicenter Study to Evaluate the Clinical Performance of SynergEyes A2 Hybrid Contact Lenses for Daily Wear Use in the Correction of Refractive Error With or Without Astigmatism in Non-diseased Eyes

Last checked: Nov 20, 2026Latest source record: Aug 25, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

125

Planned (sponsor's estimate)

Start

Aug 2009

Primary completion

Sep 2010

Study completion Sep 2010

Sponsor

Lead sponsor
SynergEyes, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jan 28, 2010

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a multicenter study to evaluate the clinical performance of the SynergEyes A2 lens in patients with refractive errors with or without astigmatism.

Conditions

  • Refractive Errors
  • Astigmatism

Interventions

  • SynergEyes A2 Hybrid Contact LensDevice

    SynergEyes A2 is a hybrid contact lens cleared by the US Food and Drug Administration (FDA) for daily wear correction of up to +20.00 and -20.00 in eyes with astigmatism up to 6.00D and for presbyopia.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Confirm current SynergEyes A2 lens design by evaluating clinical performance using objective and subjective parametersTime frame: 6 months

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Family Eye Care Center

    Campbell, California

  • SynergEyes, Inc.

    Carlsbad, California

  • Encino Optometric Center Corp.

    Encino, California

7 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.